Literature DB >> 25065974

Rural disparities in receipt of colorectal cancer screening among adults ages 50-64 with disabilities.

Willi Horner-Johnson1, Konrad Dobbertin2, Jae Chul Lee3, Elena M Andresen2.   

Abstract

BACKGROUND: Colorectal cancer is the third leading cause of cancer deaths in the United States. Early detection can reduce mortality; however, only 59% of U.S. adults age 50 and over meet recommended colorectal cancer screening guidelines. Studies in the general population have observed that rural residents are less likely to have received colorectal cancer screening than residents of urban areas.
OBJECTIVE: To determine whether urban/rural disparities in colorectal cancer screening exist among people with disabilities, similar to the disparities found in the general population.
METHODS: We analyzed Medical Expenditure Panel Survey annual data files from 2002 to 2008. We conducted logistic regression analyses to examine the relationship between urban/rural residence and ever having received screening for colorectal cancer (via colonoscopy, sigmoidoscopy, or fecal occult blood test).
RESULTS: Among U.S. adults ages 50-64 with disabilities, those living in rural areas were significantly less likely to have ever received any type of screening for colorectal cancer. The urban/rural difference was statistically significant regardless of whether or not we controlled for demographic, socioeconomic, health, and health care access variables.
CONCLUSIONS: Disparity in screening for colorectal cancer places rural residents with disabilities at greater risk for late stage diagnosis and mortality relative to people with disabilities in urban areas. Thus, there is a need for strategies to improve screening among people with disabilities in rural areas.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer screening; Health care disparities; People with disabilities; Population surveillance; Rural population

Mesh:

Year:  2014        PMID: 25065974     DOI: 10.1016/j.dhjo.2014.06.001

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  7 in total

1.  Challenges of using nationally representative, population-based surveys to assess rural cancer disparities.

Authors:  Whitney E Zahnd; Natoshia Askelson; Robin C Vanderpool; Lindsay Stradtman; Jean Edward; Paige E Farris; Victoria Petermann; Jan M Eberth
Journal:  Prev Med       Date:  2019-08-15       Impact factor: 4.018

2.  Health care eligibility and availability and health care reform: Are we addressing rural women's barriers to accessing care?

Authors:  Kristine Zimmermann; Leslie R Carnahan; Ellen Paulsey; Yamile Molina
Journal:  J Health Care Poor Underserved       Date:  2016

3.  Live birth, miscarriage, and abortion among U.S. women with and without disabilities.

Authors:  Willi Horner-Johnson; Sheetal Kulkarni-Rajasekhara; Blair G Darney; Mekhala Dissanayake; Aaron B Caughey
Journal:  Disabil Health J       Date:  2017-04-06       Impact factor: 2.554

4.  Trends in colorectal cancer screening over time for persons with and without chronic disability.

Authors:  Lisa I Iezzoni; Stephen G Kurtz; Sowmya R Rao
Journal:  Disabil Health J       Date:  2016-03-24       Impact factor: 2.554

5.  Prevalence of Cancer Screening Among Adults With Disabilities, United States, 2013.

Authors:  C Brooke Steele; Julie S Townsend; Elizabeth A Courtney-Long; Monique Young
Journal:  Prev Chronic Dis       Date:  2017-01-26       Impact factor: 2.830

6.  Cancer Disparities Experienced by People with Disabilities.

Authors:  Rosemary B Hughes; Susan Robinson-Whelen; Carly Knudson
Journal:  Int J Environ Res Public Health       Date:  2022-07-27       Impact factor: 4.614

7.  Advanced stage presentation and its determinant factors among colorectal cancer patients in Amhara regional state Referral Hospitals, Northwest Ethiopia.

Authors:  Mulugeta Wassie; Debrework Tesgera Beshah; Yenework Mulu Tiruneh
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.